Created at 6:57 p.m. Oct, 10, 2024
Author: musamalik
Related Note: 1520702156632 1
Rationale for change

UWorld qid:2062 + FA 2024 pg 240-1

Not sure where the info for this card came from but no where in any source does it say Glycopyrrolate only inhibits M3 - I think there was confusion that it doesn't cause CNS effects but that isn't because it doesn't anatongize those receptors but instead because it doesnt cross the BBB

Also multiple studies online say that glycopyrrolate can increase HR (which would be M2)

Also, I think the extra section should be updated to help explain its use in MG therapy for the corresponding uworld qid
Source: AMBOSS - https://next.amboss.com/us/article/sN0tcg?q=glycopyrrolate#Z59f7f05dcf2586c2be85d93f4c0774e8

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy


Watch Muscarinic Antagonists
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Physeo

Bootcamp
Watch associated Bootcamp video - Autonomic System : Muscarinic Antagonists
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::25171 #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::01_Parasympathetic::03_Muscarinic_antagonists #AK_Step1_v12::#AMBOSS::2OaT7k #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::09_Muscarinic_antagonists::*M3_Antagonists::Glycopyrrolate #AK_Step1_v12::#UWorld::Step::2062 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step1_v12::#Pixorize::03_Pharmacology::03_Anticholinergics::02_Glycopyrrolate #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::09_Muscarinic_Antagonists #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#B&B::15_Neuro::04_Autonomic_Nervous_System::03_ANS_Drugs:_Acetylcholine::Extra #AK_Step1_v12::#OME_banner #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::12_Muscarinic_Antagonists #AK_Step1_v12::^Other::^EXPN::BGadd